Affiliation:
1. Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond 23298-0110.
Abstract
Mice challenged intranasally with Naegleria fowleri died of primary amoebic meningoencephalitis. Mice given 30 mg of cyclophosphamide per kg of body weight daily for 10 days starting 2 days before challenge were protected. Neither cyclophosphamide nor serum from cyclophosphamide-treated mice inhibited N. fowleri in vitro. A metabolic product of cyclophosphamide, acrolein, inhibited growth and enflagellation of N. fowleri. Acrolein at 40 microM was amoebicidal. Acrolein injured starved cells and amoebae at 5 degrees C and growing N. fowleri.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference19 articles.
1. Cyclophosphamide. A review on relevant pharmacology and clinical uses;Ahmed A. R.;J. Am. Acad. Dermatol.,1984
2. Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses;Askenase P. W.;J. Exp. Med.,1975
3. Determination of the harmful biological effect of water pollutants on protozoa. II. Bacteriovorous ciliates;Bringmann G.;Z. Wasser. Abwasserforsch.,1980
4. Description of a Naegleria sp. isolated from two cases of primary amoebic meningoencephalitis and of the experimental pathological changes induced by it;Carter R. F.;J. Pathol.,1970
5. A biologically active metabolite of cyclophosphamide;Colvin M.;Cancer Res.,1973
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献